Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma (Q40430272)

20 September 2017

Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma (English)

1 reference

20 September 2017

1 reference

6

1 reference

20 September 2017

Jennifer Rubin Grandis

8

object named as

Jennifer R Grandis

1 reference

20 September 2017

7

Robert L Ferris

1 reference

20 September 2017

Stephen Y Lai

1

1 reference

20 September 2017

Erin E Childs

2

1 reference

20 September 2017

Sichuan Xi

3

1 reference

20 September 2017

Francesca M Coppelli

4

1 reference

20 September 2017

William E Gooding

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

4442-4449

1 reference

20 September 2017

27

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208635

20 September 2017

0 references

cites work

Expression of complete keratin filaments in mouse L cells augments cell migration and invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Signaling through the hematopoietic cytokine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

JAK/STAT signaling by cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Signal transduction in the erythropoietin receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

A Single Amino Acid in the DNA Binding Regions of STAT5A and STAT5B Confers Distinct DNA Binding Specificities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

The molecular biology of erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Differential function of STAT5 isoforms in head and neck cancer growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Jak kinase activity is required for lymphoma invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

The erythropoietin-receptor pathway modulates survival of cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Factors affecting the growth of head and neck squamous carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208635

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208635

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference